100 Years of Von Willebrand Disease and Upcoming Advances with Robert F. Sidonio, Jr., MD, MSc
- Conversation #1 – History and Clinical Descriptions of Von Willebrand Disease
- Conversation #2 – Disease Subgroups and Laboratory Testing for Diagnosis
- Conversation #3 – Advanced Assays and Disease Management
Alternate Warfarin Monitoring When the Prothrombin Time is Unreliable with Nicole Zantek, MD, PhD
- Conversation #1 – Antiphospholipid Antibody Pathophysiology and the Lupus Anticoagulant Test Protocol
- Conversation #2 – Anticoagulation in Antiphospholipid Syndrome
- Conversation #3 – DOACs and Warfarin
ITP and Inherited Platelet Function Disorders with Michele Lambert, MD, MSTR
- Conversation #1 – Mechanisms and Clinical Presentation
- Conversation #2 – Laboratory Diagnosis and Management of ITP
- Conversation #3 – Inherited Platelet Function Disorders
Trauma-induced Coagulopathy with Maureen Hoffman MD, PhD
- Conversation #1 – Mechanisms
- Conversation #2 – Management
- Conversation #3 – The Laboratory’s Contribution
The Many Faces of von Willebrand Factor with Prof. Emmanuel Favaloro
- Conversation #1 – VWF and Acquired von Willebrand Syndrome
- Conversation #2 – VWF and ADAMTS13: Tumor Progression and Beyond
- Conversation #3 – VWF and ADAMTS13: Thrombotic Mechanisms
Managing Direct Oral Anticoagulants with Karen Moser, MD
- Conversation #1 – DOAC History and Clinical Use
- Conversation #2 – Measuring DOACs
- Conversation #3 – DOAC Risks and Reversals